Physician profile
Lindsey B Case
NPI 1538314786
$833.54
in general payments reported to CMS, 2019-2025
15 companies · $45.42 in 2025
The $45.42 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $411 · 2022: $125 · 2023: $98.75 · 2024: $153 · 2025: $45.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $256.35 | 2021-2024 | |
| Supernus Pharmaceuticals, INC. | $164.19 | 2021-2023 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $79.27 | 2021-2025 | Ninlaro |
| Merck Sharp & Dohme LLC | $58.61 | 2021-2022 | |
| Adlon Therapeutics L.P. | $56.02 | 2021 | |
| Neos Therapeutics, Lp | $30.14 | 2021 | |
| Pfizer INC. | $29.74 | 2021 | |
| Teleflex LLC | $28.53 | 2023 | Turnpike |
| Kaleo, INC. | $27.30 | 2021 | |
| Alk-Abello, INC | $23.88 | 2021 | |
| Glaxosmithkline, LLC. | $21.38 | 2021 | |
| Abbott Laboratories | $18.11 | 2025 | Id Now Instrument |
| Cranial Technologies, INC | $14.92 | 2021 | |
| Abbvie INC. | $13.12 | 2021 | |
| Seqirus USA INC | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Case listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.